ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease

February 20, 1998

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Cech To Step Down At HHMI In 2009.

April 18, 2008